Impact of CLEC3B mRNA expression on genetic landscape and immune tumor-microenvironment in NSCLC. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a ...
Combination mTORC1/2 and BCL- XL inhibition in endocrine and CDK4/6-resistant estrogen receptor-positive breast cancer. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results